These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Tumor necrosis factor-alpha and hematopoietic progenitors: effects of tumor necrosis factor on the growth of erythroid progenitors CFU-E and BFU-E and the hematopoietic cell lines K562, HL60, and HEL cells. Roodman GD, Bird A, Hutzler D, Montgomery W. Exp Hematol; 1987 Oct; 15(9):928-35. PubMed ID: 2820776 [Abstract] [Full Text] [Related]
3. The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: synergism of tumor necrosis factor and interferon-gamma. Broxmeyer HE, Williams DE, Lu L, Cooper S, Anderson SL, Beyer GS, Hoffman R, Rubin BY. J Immunol; 1986 Jun 15; 136(12):4487-95. PubMed ID: 3086433 [Abstract] [Full Text] [Related]
4. Effects of recombinant human tumor necrosis factor on highly enriched hematopoietic progenitor cell populations from normal human bone marrow and peripheral blood and bone marrow from patients with chronic myeloid leukemia. Wisniewski D, Strife A, Atzpodien J, Clarkson BD. Cancer Res; 1987 Sep 15; 47(18):4788-94. PubMed ID: 3040231 [Abstract] [Full Text] [Related]
5. In vitro sensitivity of post-bone marrow transplantation CFU-GM and BFU-E to TNF-alpha and IFN-gamma. Papadakis V, Ferguson KF, Heller G, Kernan NA. Exp Hematol; 1995 Dec 15; 23(14):1422-30. PubMed ID: 8542927 [Abstract] [Full Text] [Related]
6. Interferon-gamma exerts its negative regulatory effect primarily on the earliest stages of murine erythroid progenitor cell development. Wang CQ, Udupa KB, Lipschitz DA. J Cell Physiol; 1995 Jan 15; 162(1):134-8. PubMed ID: 7814445 [Abstract] [Full Text] [Related]
7. Suppressive biological activity of a synthetic pentapeptide on highly enriched human and murine marrow hematopoietic progenitors: synergism with recombinant human tumor necrosis factor-alpha and interferon-gamma. Lu L, Foa P, Chillemi F, Shen RN, Lin ZH, Carow C, Broxmeyer HE. Exp Hematol; 1989 Oct 15; 17(9):935-41. PubMed ID: 2506072 [Abstract] [Full Text] [Related]
8. Differential sensitivity of adherent CFU-blast, CFU-mix, BFU-E, and CFU-GM to mafosfamide: implications for adjusted dose purging in autologous bone marrow transplantation. Carlo-Stella C, Mangoni L, Almici C, Garau D, Craviotto L, Piovani G, Caramatti C, Rizzoli V. Exp Hematol; 1992 Mar 15; 20(3):328-33. PubMed ID: 1568448 [Abstract] [Full Text] [Related]
9. Recombinant human tumor necrosis factors alpha and beta stimulate fibroblasts to produce hemopoietic growth factors in vitro. Zucali JR, Broxmeyer HE, Gross MA, Dinarello CA. J Immunol; 1988 Feb 01; 140(3):840-4. PubMed ID: 3276782 [Abstract] [Full Text] [Related]
10. In vitro sensitivity of human hematopoietic progenitor cells to 4-hydroperoxycyclophosphamide. Ratajczak MZ, Ratajczak J, Kuczynski W, Light B, Lusk EJ, Gewirtz AM. Exp Hematol; 1993 Dec 01; 21(13):1663-7. PubMed ID: 8243568 [Abstract] [Full Text] [Related]
11. Secretion of tumor necrosis factor-alpha by fresh human acute nonlymphoblastic leukemic cells: role in the disappearance of normal CFU-GM progenitors. Kobari L, Weil D, Lemoine FM, Dubois C, Thiam D, Baillou C, Guigon M, Gorin NC, Najman A. Exp Hematol; 1990 Dec 01; 18(11):1187-92. PubMed ID: 1699775 [Abstract] [Full Text] [Related]
12. The effects of transforming growth factor beta 3 on the growth of highly enriched hematopoietic progenitor cells derived from normal human bone marrow and peripheral blood. Strife A, Lambek C, Perez A, Darzynkiewicz Z, Skierski J, Gulati S, Haley JD, ten Dijke P, Iwata KK, Clarkson BD. Cancer Res; 1991 Sep 15; 51(18):4828-36. PubMed ID: 1893375 [Abstract] [Full Text] [Related]
13. Increased resistance of PIG-A- bone marrow progenitors to tumor necrosis factor a and interferon gamma: possible implications for the in vivo dominance of paroxysmal nocturnal hemoglobinuria clones. Barcellini W, Fermo E, Guia Imperiali F, Zaninoni A, Bianchi P, Boschetti C, Zanella A. Haematologica; 2004 Jun 15; 89(6):651-6. PubMed ID: 15194531 [Abstract] [Full Text] [Related]
14. Opposite effect of tumor necrosis factor alpha on granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor-dependent growth of normal and leukemic hemopoietic progenitors. Piacibello W, Sanavio F, Severino A, Morelli S, Vaira AM, Stacchini A, Aglietta M. Cancer Res; 1990 Aug 15; 50(16):5065-71. PubMed ID: 1696165 [Abstract] [Full Text] [Related]
15. Effect of deoxycytidine on 2-chloro-deoxyadenosine-mediated growth inhibition of normal human erythroid and myeloid progenitor cells. Bilgeri R, Petzer AL, Zilian U, Geisen FH, Schirmer M, Haun M, Konwalinka G. Exp Hematol; 1993 Mar 15; 21(3):432-7. PubMed ID: 8095026 [Abstract] [Full Text] [Related]
16. Feline leukemia virus infection downmodulates the production of growth-inhibitory activity by marrow stromal cells. Linenberger ML, Dow SW, Abkowitz JL. Exp Hematol; 1995 Sep 15; 23(10):1069-79. PubMed ID: 7656928 [Abstract] [Full Text] [Related]
17. Thy-1 is a differentiation antigen that characterizes immature murine erythroid and myeloid hematopoietic progenitors. Miller BA, Lipton JM, Linch DC, Burakoff SJ, Nathan DG. J Cell Physiol; 1985 Apr 15; 123(1):25-32. PubMed ID: 2857726 [Abstract] [Full Text] [Related]
18. Tumor necrosis factor-alpha and CD95 ligation suppress erythropoiesis in Fanconi anemia C gene knockout mice. Otsuki T, Nagakura S, Wang J, Bloom M, Grompe M, Liu JM. J Cell Physiol; 1999 Apr 15; 179(1):79-86. PubMed ID: 10082135 [Abstract] [Full Text] [Related]
19. Thymic humoral factor-gamma 2, an immunoregulatory peptide, enhances human hematopoietic progenitor cell growth. Barak Y, Hahn T, Pecht M, Karov Y, Berrebi A, Zaizov R, Stark B, Buchner V, Burstein Y, Trainin N. Exp Hematol; 1992 Feb 15; 20(2):173-7. PubMed ID: 1544385 [Abstract] [Full Text] [Related]
20. Interactions of tumor necrosis factor with granulocyte-macrophage colony-stimulating factor and other cytokines in the regulation of dendritic cell growth in vitro from early bipotent CD34+ progenitors in human bone marrow. Reid CD, Stackpoole A, Meager A, Tikerpae J. J Immunol; 1992 Oct 15; 149(8):2681-8. PubMed ID: 1383322 [Abstract] [Full Text] [Related] Page: [Next] [New Search]